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Multidisciplinary treatment of colorectal cancer metastases:
reaching consensus
This issue of HPB offers the proceedings of the 18 January 2012 AHPBA/SSO/SSAT Consensus Conference
dedicated to the multidisciplinary diagnosis and treatment of colorectal cancer liver metastases (CRLM).
This conference was felt necessary only 6 years after a similar CRLM conference because of the pace,
significance and implementation of novel treatment approaches. Over three sessions, international experts
assembled to consider and build consensus on issues of selection for hepatic resection, locoregional surgical
and interventional therapies, and systemic cytotoxic and biological therapies. This one day conference
brought together surgeons, medical oncologists and pathologists to yield a multidisciplinary consensus.
Three manuscripts follow which breakdown the topics considered in these three realms, and offer expert
consensus statements for each. Further, well known thought-leaders, who served as expert panelists during
these sessions, now provide insightful and stimulating commentaries of the conference process and the
resulting consensus statements. Historically, these consensus conferences have been very important,
productive and well-received. We congratulate all authors and participants for their efforts to advance our
knowledge of where the treatment of CRLM is and should be today.
Mark Callery
Management of the incidental liver lesion
With the exponential increase in the use of cross sectional imaging over the last two decades, HPB surgeons
are increasingly being asked to advise on the management of benign or incidentally detected mass lesions. In
this issue of HPB, Mezhir et al. of the Memorial Sloan-Kettering Cancer Center report an 18-year experience
in the management of such mass lesions and provide a management algorithm for each individual lesion. A
total of 285 patients were identified from their institutional database of which 41% underwent immediate
resection. Of the remaining 59% of patients that were followed for a median of 30 months, only 5%
(n = 8/168) subsequently underwent resection, none of which had undergone malignant change. Not sur-
prising to most clinicians is the observation of markedly reduced rates of resection due to diagnostic
uncertainty in recent years (29% reduced to 13%). One does wonder, however, whether these rates could
have been further reduced if there had been more formalized use of MRI as it would appear that only 44%
of patients actually had an MRI. From the data provided, it is not possible to tease out the frequency of use
of MRI in those with diagnostic uncertainty or by time of presentation. Although these intervention rates
may seem high, it is important to assess these data in context because, as the authors rightly point out, there
is selection bias due to referral patterns. Furthermore, the review was conducted over a period of significant
change and the studied patients made up only 3.4% of the overall proportion of hepatic resections. The
strength of this paper is the detailed follow up of patients who were observed. It is clear that once a definitive
diagnosis is made of haemangioma or focal nodular hyperplasia then prolonged follow up would seem to be
unnecessary as resection will only be indicated if symptoms develop.
Saxon Connor
Liver resection or liver transplantation for solitary hepatitis C virus
associated hepatocellular carcinoma?
In the September issue of HPB we published a meta-analysis which showed that outcomes for patients with
HCC from all causes were better after liver transplantation than after liver resection but that this benefit
disappeared when an intention to treat analysis was performed (Dhir et al., HPB 2012; 14 (9), 635–645). In
the current issue ofHPB, Sogawa and colleagues from theMount SinaiMedical Center present evidence based
on patients with hepatitis C virus associated solitary HCC. This group has been the most contentious
regarding whether it is better to undertake resection or to transplant the liver. Their study shows that a third
of patients with HCV-associated solitary HCC who were listed for transplant died or progressed outside of
transplant criteria while waiting for liver transplantation. The intention to treat analysis showed a superior
survival of 62months versus 31months for patients who underwent liver resection compared with those that
underwent liver transplantation; this difference did not achieve statistical significance presumably because
the numbers of patients were relatively small. Recurrence rates for HCC were significantly higher in resected
than transplanted patients but almost all recurrences were intrahepatic and a third underwent salvage
transplantation and 40% underwent either repeat resection or ablation. The decision about how best to
manage HCC ultimately depends on the availability of livers for transplantation, the status of the patients’
liver function and the outcomes of the individual centre. However, this study clearly shows that, based on
intention to treat analyses, resection of solitary HCC on a background of hepatitis C virus is a reasonable
strategy to adopt in a landscape with limited organ availability for transplantation.
Stephen J Wigmore
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